Literature DB >> 10410913

Peanut oil in vitamin A and D preparations: reactions to skin test and manifestation of symptoms.

I Kull1, E Hallner, G Lilja, A C Ohman-Johansson, H Oman, M Wickman.   

Abstract

The aim of this study was to establish whether there is a link between sensitisation to peanut and exposure to peanut oil in vitamin A and D preparations. Forty-one children with a positive in vivo or in vitro test towards peanut were included. Twenty-one children had consumed vitamins A and D in oil solution, 14 in water solution, and 6 both types. Refined and unrefined peanut oils were obtained and skin prick test extracts were prepared. None of the children exhibited a positive SPT in response to the refined peanut extract. In contrast, 15 children exhibited a positive SPT to the unrefined extract. There was no significant difference in the number of children reacting clinically to peanut exposure who had received vitamins A and D in oil-based or water-based formulations. However, children with clinical allergy to peanut and who had exclusively consumed vitamin A and D in peanut oil, exhibited a greater number of different allergic symptoms upon consumption of peanut compared with clinical allergic children who had consumed the vitamins in water solution or both types (p<0.01). This study indicates that sensitisation to peanut during childhood through consumption of vitamins A and D in oil-based solution seems unlikely, but its consumption may contribute to the development of a wider range of clinical symptoms due to peanut exposure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10410913     DOI: 10.1034/j.1398-9995.1999.101019.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  1 in total

1.  A taste comparison of two different liquid colecalciferol (vitamin D3) preparations in healthy newborns and infants.

Authors:  Juan M Martínez; Federica Bartoli; Elena Recaldini; Laure Lavanchy; Mario G Bianchetti
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.